Literature DB >> 11262720

Cognitive impairment with no dementia (CIND): longitudinal studies, the findings, and the issues.

H Tuokko1, R J Frerichs.   

Abstract

Identification of persons at risk for developing dementia is of increasing importance as the proportion of persons over the age of 65 years grows globally. This review examines the neuropsychological literature specifically addressing the concept of impaired cognitive functioning of insufficient magnitude to warrant a diagnosis of dementia and its meaning with respect to the development of dementia. Although the most obvious finding in the literature is that persons with impaired cognitive functioning have varied outcomes, it is clear that a significant proportion of persons with mild cognitive impairment progress to dementia over a 1- to 2-year interval and approximately 50% progress to dementia by 5 years. The best and most commonly identified predictors of decline to dementia include age and lower baseline performance on neuropsychological measures (e.g., measures of memory). In discussing these findings, issues related to sample definition, sample selection, and methodology are identified and recommendations for future research are provided.

Entities:  

Mesh:

Year:  2000        PMID: 11262720     DOI: 10.1076/clin.14.4.504.7200

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  13 in total

1.  Prevalence of neuropsychiatric symptoms in CIND and its subtypes: the Cache County Study.

Authors:  Matthew E Peters; Paul B Rosenberg; Martin Steinberg; JoAnn T Tschanz; Maria C Norton; Kathleen A Welsh-Bohmer; Kathleen M Hayden; John C S Breitner; Constantine G Lyketsos
Journal:  Am J Geriatr Psychiatry       Date:  2012-05       Impact factor: 4.105

2.  Harm avoidance and risk of Alzheimer's disease.

Authors:  Robert S Wilson; Patricia A Boyle; Aron S Buchman; Lei Yu; Steven E Arnold; David A Bennett
Journal:  Psychosom Med       Date:  2011-09-23       Impact factor: 4.312

Review 3.  Depression in cognitive impairment.

Authors:  Laurel D Pellegrino; Matthew E Peters; Constantine G Lyketsos; Christopher M Marano
Journal:  Curr Psychiatry Rep       Date:  2013-09       Impact factor: 5.285

4.  Subtypes of mild cognitive impairment in older postmenopausal women: the Women's Health Initiative Memory Study.

Authors:  Stephen R Rapp; Claudine Legault; Victor W Henderson; Robert L Brunner; Kamal Masaki; Beverly Jones; John Absher; Leon Thal
Journal:  Alzheimer Dis Assoc Disord       Date:  2010 Jul-Sep       Impact factor: 2.703

5.  Neuropsychiatric symptoms as risk factors for progression from CIND to dementia: the Cache County Study.

Authors:  M E Peters; P B Rosenberg; M Steinberg; M C Norton; K A Welsh-Bohmer; K M Hayden; J Breitner; J T Tschanz; C G Lyketsos
Journal:  Am J Geriatr Psychiatry       Date:  2013-02-06       Impact factor: 4.105

6.  Cognitive impairment in nondemented oldest-old: prevalence and relationship to cardiovascular risk factors.

Authors:  Carrie B Peltz; María M Corrada; Daniel J Berlau; Claudia H Kawas
Journal:  Alzheimers Dement       Date:  2011-11-04       Impact factor: 21.566

7.  Late-life dementia predicts mortality beyond established midlife risk factors.

Authors:  Michal Schnaider Beeri; Uri Goldbourt
Journal:  Am J Geriatr Psychiatry       Date:  2011-01       Impact factor: 4.105

Review 8.  Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia.

Authors:  Howard Chertkow; Fadi Massoud; Ziad Nasreddine; Sylvie Belleville; Yves Joanette; Christian Bocti; Valérie Drolet; John Kirk; Morris Freedman; Howard Bergman
Journal:  CMAJ       Date:  2008-05-06       Impact factor: 8.262

9.  Religious education and midlife observance are associated with dementia three decades later in Israeli men.

Authors:  Michal Schnaider Beeri; Michael Davidson; Jeremy M Silverman; James Schmeidler; Ramit Ravona Springer; Shlomo Noy; Uri Goldbourt
Journal:  J Clin Epidemiol       Date:  2008-06-06       Impact factor: 6.437

10.  The PACE study: a randomised clinical trial of cognitive activity (CA) for older adults with mild cognitive impairment (MCI).

Authors:  Mandy R Vidovich; Nicola T Lautenschlager; Leon Flicker; Linda Clare; Osvaldo P Almeida
Journal:  Trials       Date:  2009-12-14       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.